Shenyang Xingqi Pharmaceutical Co Ltd Market Cap ($1.30 Billion)
Market Cap & Net Worth: Shenyang Xingqi Pharmaceutical Co Ltd (300573)
Shenyang Xingqi Pharmaceutical Co Ltd market cap. Shenyang Xingqi Pharmaceutical Co Ltd (SHE:300573) has a market capitalization of $1.30 Billion (CN¥8.88 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #7599 globally and #1630 in its home market, demonstrating a 9.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenyang Xingqi Pharmaceutical Co Ltd's stock price CN¥36.04 by its total outstanding shares 246429527 (246.43 Million). Also see Shenyang Xingqi Pharmaceutical Co Ltd (300573) cash conversion ratio for how efficiently the company converts equity into cash flow.
Shenyang Xingqi Pharmaceutical Co Ltd Market Cap History (2016–2026)
Shenyang Xingqi Pharmaceutical Co Ltd market cap history from 2016 to 2026. Data shows growth from $588.42 Million to $1.30 Billion (26.34% CAGR). Check latest Shenyang Xingqi Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Index Memberships
Shenyang Xingqi Pharmaceutical Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$932.54 Billion | 0.14% | #92 of 100 |
Weight: Shenyang Xingqi Pharmaceutical Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shenyang Xingqi Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenyang Xingqi Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shenyang Xingqi Pharmaceutical Co Ltd (300573) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.29x
Shenyang Xingqi Pharmaceutical Co Ltd's market cap is 1.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.44x
Shenyang Xingqi Pharmaceutical Co Ltd's market cap is 7.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $588.42 Million | $339.10 Million | $54.28 Million | 1.74x | 10.84x |
| 2017 | $428.74 Million | $360.01 Million | $39.44 Million | 1.19x | 10.87x |
| 2018 | $293.89 Million | $431.20 Million | $13.66 Million | 0.68x | 21.52x |
| 2019 | $1.29 Billion | $542.43 Million | $35.89 Million | 2.38x | 35.91x |
| 2020 | $1.68 Billion | $688.68 Million | $87.98 Million | 2.43x | 19.04x |
| 2021 | $2.42 Billion | $1.03 Billion | $194.70 Million | 2.35x | 12.40x |
| 2022 | $2.23 Billion | $1.25 Billion | $211.68 Million | 1.78x | 10.53x |
| 2023 | $4.60 Billion | $1.47 Billion | $240.04 Million | 3.13x | 19.16x |
| 2024 | $2.52 Billion | $1.94 Billion | $338.06 Million | 1.29x | 7.44x |
Competitor Companies of 300573 by Market Capitalization
Companies near Shenyang Xingqi Pharmaceutical Co Ltd in the global market cap rankings as of November 5, 2026. Also see 300573 total assets for a full breakdown of the balance sheet.
Key companies related to Shenyang Xingqi Pharmaceutical Co Ltd by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #174 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #244 globally with a market cap of $102.37 Billion USD ( €87.56 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #539 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #174 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $482.10 |
| #244 | EssilorLuxottica S. A. | PA:EL | $102.37 Billion | €189.10 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €94.50 |
| #539 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Shenyang Xingqi Pharmaceutical Co Ltd (2016–2026)
Market capitalization of Shenyang Xingqi Pharmaceutical Co Ltd from 2016 to today. Between 2016 and today, Shenyang Xingqi Pharmaceutical Co Ltd's market cap moved from $588.42 Million to $ 1.30 Billion, with a yearly change of 26.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.30 Billion | -48.73% |
| 2025 | CN¥2.53 Billion | +0.73% |
| 2024 | CN¥2.52 Billion | -45.29% |
| 2023 | CN¥4.60 Billion | +106.39% |
| 2022 | CN¥2.23 Billion | -7.72% |
| 2021 | CN¥2.42 Billion | +44.17% |
| 2020 | CN¥1.68 Billion | +29.96% |
| 2019 | CN¥1.29 Billion | +338.61% |
| 2018 | CN¥293.89 Million | -31.45% |
| 2017 | CN¥428.74 Million | -27.14% |
| 2016 | CN¥588.42 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Shenyang Xingqi Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.30 Billion USD |
| MoneyControl | $1.30 Billion USD |
| MarketWatch | $1.30 Billion USD |
| marketcap.company | $1.30 Billion USD |
| Reuters | $1.30 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shenyang Xingqi Pharmaceutical Co Ltd
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People's Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs… Read more